GlassScriptPhysician profile
Jane Offei-Darko
NPI 1346304995
$1,988.74
in general payments reported to CMS, 2019-2025
8 companies · $688 in 2025
The $688 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $102 · 2022: $344 · 2023: $497 · 2024: $357 · 2025: $688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,542.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $763.98 | 2021-2025 | |
| Viiv Healthcare Company | $546.78 | 2023-2025 | Apretude |
| Pfizer INC. | $343.52 | 2023-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $147.79 | 2022 | |
| Abbvie INC. | $110.76 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $26.39 | 2022 | |
| Amgen INC. | $26.25 | 2025 | Repatha |
| Exact Sciences Corporation | $23.27 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Offei-Darko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.